CellWell record HH-119066
Glucagon-Like Peptide-1 Receptor Agonists as a Non-surgical Alternative to Bariatric Surgery for Weight Loss: A Review
Chuh Steven; Thangwaritorn Skylynn; Haghighat Bardya; Bhalla Megha; Vuong Helen; Duo Lee; Fateh Entabi; Sudhakar Pemminati
2026
In plain language
Glucagon-like peptide-1 agonists reduced obesity and improved glycemic control, with weight loss-dependent improvements in depression and anxiety severity.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-119066
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.